New hope for young migraine sufferers: Long-Term study tests monthly shot

NCT ID NCT04530110

Completed Disease control Sponsor: Teva Branded Pharmaceutical Products R&D LLC Source: ClinicalTrials.gov ↗

Summary

This study aimed to check the long-term safety and effectiveness of a monthly injection called fremanezumab for preventing migraines in children and teenagers aged 6 to 17. It involved 506 young participants who had already been in related studies, tracking them for up to 7 years. The main goal was to see how safe the treatment was over a long period, while also measuring if it reduced the number and severity of migraine days.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Teva Investigational Site 11179

Ottawa, Ontario, K2G 1W2, Canada
Teva Investigational Site 11181

Montreal, Quebec, H3H 2R9, Canada
Teva Investigational Site 11182

Ottawa, Ontario, K1H 8L1, Canada
Teva Investigational Site 14243

Atlanta, Georgia, 30328, United States
Teva Investigational Site 14244

Jacksonville, Florida, 32256, United States
Teva Investigational Site 14245

Wichita, Kansas, 67206, United States
Teva Investigational Site 14246

Waltham, Massachusetts, 02451, United States
Teva Investigational Site 14248

Raleigh, North Carolina, 27607, United States
Teva Investigational Site 14250

West Palm Beach, Florida, 33407, United States
Teva Investigational Site 14251

Ann Arbor, Michigan, 48104, United States
Teva Investigational Site 14252

Austin, Texas, 78731, United States
Teva Investigational Site 14255

West Palm Beach, Florida, 33409, United States
Teva Investigational Site 14256

Bridgeton, Missouri, 63044-2513, United States
Teva Investigational Site 14257

Oklahoma City, Oklahoma, 73112, United States
Teva Investigational Site 14258

Savannah, Georgia, 31406, United States
Teva Investigational Site 14263

Hoffman Estates, Illinois, 60169, United States
Teva Investigational Site 14264

Cincinnati, Ohio, 45229-3039, United States
Teva Investigational Site 14270

Minneapolis, Minnesota, 55402, United States
Teva Investigational Site 14273

Austin, Texas, 78759, United States
Teva Investigational Site 14276

Amherst, New York, 14226, United States
Teva Investigational Site 14319

Aurora, Colorado, 80045, United States
Teva Investigational Site 14323

Norfolk, Virginia, 23510, United States
Teva Investigational Site 14325

Miami, Florida, 33155, United States
Teva Investigational Site 14327

Louisville, Kentucky, 40202, United States
Teva Investigational Site 14360

Covington, Louisiana, 70433, United States
Teva Investigational Site 14363

Tulsa, Oklahoma, 74136, United States
Teva Investigational Site 14364

Philadelphia, Pennsylvania, 19104-4318, United States
Teva Investigational Site 14365

Baltimore, Maryland, 21201, United States
Teva Investigational Site 14367

Dallas, Texas, 75235-7701, United States
Teva Investigational Site 14368

Colorado Springs, Colorado, 80907, United States
Teva Investigational Site 14371

New Brunswick, New Jersey, 08901, United States
Teva Investigational Site 14374

Bristol, Tennessee, 37620, United States
Teva Investigational Site 14375

Salt Lake City, Utah, 84109, United States
Teva Investigational Site 14376

Ridgeland, Mississippi, 39157, United States
Teva Investigational Site 14377

Durham, North Carolina, 27710, United States
Teva Investigational Site 30225

Rome, 00163, Italy
Teva Investigational Site 30226

Milan, 20148, Italy
Teva Investigational Site 30227

Pavia, 27100, Italy
Teva Investigational Site 30228

Milan, 20133, Italy
Teva Investigational Site 30230

Florence, 50139, Italy
Teva Investigational Site 30238

Padua, 35128, Italy
Teva Investigational Site 30239

Milan, 20132, Italy
Teva Investigational Site 31265

Valladolid, 47010, Spain
Teva Investigational Site 31270

Valencia, 46026, Spain
Teva Investigational Site 31271

Barcelona, 08035, Spain
Teva Investigational Site 32726

Leipzig, 04177, Germany
Teva Investigational Site 32728

Bad Homburg, 61350, Germany
Teva Investigational Site 32729

Berlin, 13353, Germany
Teva Investigational Site 38135

Nijmegen, 6532 SZ, Netherlands
Teva Investigational Site 38136

Rotterdam, 3015 GD, Netherlands
Teva Investigational Site 38138

Doetinchem, 7009 BL, Netherlands
Teva Investigational Site 40049

Kuopio, 70210, Finland
Teva Investigational Site 40052

Tampere, 33521, Finland
Teva Investigational Site 40053

Helsinki, 00380, Finland
Teva Investigational Site 40054

Oulu, 90100, Finland
Teva Investigational Site 53437

Kielce, 25-316, Poland
Teva Investigational Site 53439

Poznan, 60-355, Poland
Teva Investigational Site 53440

Lublin, 20-582, Poland
Teva Investigational Site 53441

Gdansk, 80-389, Poland
Teva Investigational Site 53442

Szczecin, 70-111, Poland
Teva Investigational Site 53443

Krakow, 30-363, Poland
Teva Investigational Site 53451

Poznan, 61-731, Poland
Teva Investigational Site 53452

Krakow, 30-539, Poland
Teva Investigational Site 80164

Safed, 1311001, Israel
Teva Investigational Site 80165

Tel Aviv, 6423906, Israel
Teva Investigational Site 80166

Haifa, 3104802, Israel
Teva Investigational Site 80167

Ramat Gan, 5265601, Israel
Teva Investigational Site 80168

Holon, 58100, Israel
Teva Investigational Site 80169

Jerusalem, 9124001, Israel
Teva Investigational Site 80170

Be’er Ya‘aqov, 7033001, Israel

Conditions

Explore the condition pages connected to this study.

MIGRAINE